pH-Responsive Assembly of Gold Nanoparticles and “Spatiotemporally Concerted” Drug Release for Synergistic Cancer Therapy

ACS Nano ◽  
2013 ◽  
Vol 7 (4) ◽  
pp. 3388-3402 ◽  
Author(s):  
Jutaek Nam ◽  
Wan-Geun La ◽  
Sekyu Hwang ◽  
Yeong Su Ha ◽  
Nokyoung Park ◽  
...  
Biomaterials ◽  
2018 ◽  
Vol 154 ◽  
pp. 169-181 ◽  
Author(s):  
Yanan Tan ◽  
Yun Zhu ◽  
Yue Zhao ◽  
Lijuan Wen ◽  
Tingting Meng ◽  
...  

2014 ◽  
Vol 50 (80) ◽  
pp. 11852-11855 ◽  
Author(s):  
Shi-Ying Li ◽  
Li-Han Liu ◽  
Hui-Zhen Jia ◽  
Wen-Xiu Qiu ◽  
Lei Rong ◽  
...  

2015 ◽  
Vol 3 (37) ◽  
pp. 7401-7407 ◽  
Author(s):  
Haibo Wang ◽  
Gongyan Liu ◽  
Shihua Dong ◽  
Junjie Xiong ◽  
Zongliang Du ◽  
...  

A multifunctional drug delivery system with AIE character was designed and constructed for simultaneous cellular imaging and pH-triggered drug release.


RSC Advances ◽  
2017 ◽  
Vol 7 (43) ◽  
pp. 26640-26649 ◽  
Author(s):  
Tian Zhong ◽  
Jia Fu ◽  
Ran Huang ◽  
Lianjiang Tan

Core–shell CuS(DOX)@CS nanospheres with pH-responsive drug release ability and photothermal conversion properties are synthesized for synergistic cancer therapy.


2015 ◽  
Vol 3 (46) ◽  
pp. 9033-9042 ◽  
Author(s):  
Mengni He ◽  
Jiajia Zhou ◽  
Jian Chen ◽  
Fangcai Zheng ◽  
Dongdong Wang ◽  
...  

Controlled drug release is a promising approach for cancer therapy due to its merits of reduced systemic toxicity and enhanced antitumor efficacy.


Author(s):  
Pradipta Das ◽  
Subash Das ◽  
Niranjan Rout ◽  
Umesh Kumar Parida

In this study, we developed encapsulating doxorubicin (DOX) drug loaded CS coated Vitis viniferaL mediated gold nanoparticles (V-AuNPs) [DOX loaded CS coated-V-AuNPs]. V-AuNPs were characterized by UV-Visible spectrophotometer, FTIR, XRD, TEM. The DOX-loaded CS coated-V-AuNPs was evaluated by particle size, surface charge, entrapment efficacy, and effect of pH in drug release profile. Additionally, drug entrapment efficacy (EE) was up to 56%; CS-DOX- V-AuNPs showed a pH-responsive drug release in vitro. The DOX release was nearly 84% at pH 5.4 and 67% at pH 7.4.The current work proves the potential of pharmacology that involves a fusion of advanced techniques from nanoscience to develop the biology and used in the fields of drug delivery, Bio Sensor Manufacturing, Medical therapy and the development of DOX-loaded CS coated-V-AuNPs nanoparticle for sustained, controlled release and may be useful for breast cancer treatment.


2020 ◽  
Vol 8 (40) ◽  
pp. 9258-9268
Author(s):  
Chander Amgoth ◽  
Shuai Chen ◽  
Tirupathi Malavath ◽  
Guping Tang

Herein, the synthesis of an amino-acid-based di-block copolymer (di-BCP) in-between an l-glutamic acid-5-benzyl ester and L-aspartic acid-4-benzyl ester [(l-GluA-5-BE)-b-(l-AspA-4-BE)] has been reported.


Langmuir ◽  
2019 ◽  
Vol 35 (49) ◽  
pp. 16266-16274 ◽  
Author(s):  
Syed Akif Raza Kazmi ◽  
Muhammad Zahid Qureshi ◽  
Shaukat Ali ◽  
Jean-Francois Masson

2018 ◽  
Vol 25 (25) ◽  
pp. 3036-3057 ◽  
Author(s):  
Xiao Sun ◽  
Guilong Zhang ◽  
Zhengyan Wu

According to the differences of microenvironments between tumors and healthy tissues, if the anticancer drugs or magnetic resonance contrast agents (MRCAs) can be controlled to precisely match physiological needs at targeted tumor sites, it is expected to acquire better therapeutic efficacy and more accurate diagnosis. Over the decade, stimuli-responsive nanomaterials have been a research hotspot for cancer treatment and diagnosis because they show many excellent functions, such as in vivo imaging, combined targeting drug delivery and systemic controlled release, extended circulation time, etc. Among the various stimuli nanosystems, pH-stimuli mode is regarded as the most general strategy because of solid tumors acidosis. When exposed to weakly acidic tumor microenvironment, pH-responsive nanoplatforms can generate physicochemical changes for their structure and surface characteristics, causing drug release or contrast enhancement. In this review, we focused on the designs of various pH-responsive nanoplatforms and discussed the mechanisms of controlled drug release or switch on-off in MRCAs. This review also discussed the efficacy of cellular internalization for these nanoplatforms via endocytosis of acidic tumor cell. Meanwhile, nanoplatforms response to acidic intracellular pH (such as endosome, lysosome) are discussed, along with approaches for improving drug release performance and magnetic resonance contrast enhancement. A greater understanding of these pH-responsive nanoplatforms will help design more efficient nanomedicine to address the challenges encountered in conventional diagnosis and chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document